EA202092749A1 - Композиции, содержащие аминокислоты, для применения в предотвращении и лечении заболеваний печени - Google Patents

Композиции, содержащие аминокислоты, для применения в предотвращении и лечении заболеваний печени

Info

Publication number
EA202092749A1
EA202092749A1 EA202092749A EA202092749A EA202092749A1 EA 202092749 A1 EA202092749 A1 EA 202092749A1 EA 202092749 A EA202092749 A EA 202092749A EA 202092749 A EA202092749 A EA 202092749A EA 202092749 A1 EA202092749 A1 EA 202092749A1
Authority
EA
Eurasian Patent Office
Prior art keywords
prevention
treatment
amino acids
compositions containing
containing amino
Prior art date
Application number
EA202092749A
Other languages
English (en)
Inventor
Паоло Лука Мария Джорджетти
Original Assignee
Профешнл Диететикс Интернешнл С.Р.Л.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Профешнл Диететикс Интернешнл С.Р.Л. filed Critical Профешнл Диететикс Интернешнл С.Р.Л.
Publication of EA202092749A1 publication Critical patent/EA202092749A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51—Thiamines, e.g. vitamin B1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Композиция для применения в предотвращении и/или лечении заболевания печени у млекопитающего, содержащая активный агент, где указанный активный агент содержит аминокислоты: лейцин, изолейцин, валин, треонин, лизин и карбоновые кислоты: лимонную кислоту, янтарную кислоту, яблочную кислоту.
EA202092749A 2018-06-27 2019-04-02 Композиции, содержащие аминокислоты, для применения в предотвращении и лечении заболеваний печени EA202092749A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT102018000006725A IT201800006725A1 (it) 2018-06-27 2018-06-27 Composizioni comprendenti aminoacidi per l'uso nella prevenzione e nel trattamento di malattie epatiche
PCT/IB2019/052694 WO2020003013A1 (en) 2018-06-27 2019-04-02 Compositions comprising amino acids for use in the prevention and treatment of liver diseases

Publications (1)

Publication Number Publication Date
EA202092749A1 true EA202092749A1 (ru) 2021-06-23

Family

ID=63491976

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202092749A EA202092749A1 (ru) 2018-06-27 2019-04-02 Композиции, содержащие аминокислоты, для применения в предотвращении и лечении заболеваний печени

Country Status (22)

Country Link
US (1) US20210260011A1 (ru)
EP (1) EP3586837B1 (ru)
JP (1) JP7347744B2 (ru)
KR (1) KR20210025611A (ru)
CN (1) CN112334129A (ru)
AU (1) AU2019293293A1 (ru)
BR (1) BR112020026431A2 (ru)
CA (1) CA3104839A1 (ru)
CL (1) CL2020003209A1 (ru)
CY (1) CY1124030T1 (ru)
DK (1) DK3586837T3 (ru)
EA (1) EA202092749A1 (ru)
ES (1) ES2858355T3 (ru)
IT (1) IT201800006725A1 (ru)
LT (1) LT3586837T (ru)
MX (1) MX2020013471A (ru)
PH (1) PH12020552254A1 (ru)
PL (1) PL3586837T3 (ru)
RS (1) RS61613B1 (ru)
SG (1) SG11202012297XA (ru)
WO (1) WO2020003013A1 (ru)
ZA (1) ZA202007834B (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201700087376A1 (it) 2017-07-28 2019-01-28 Professional Dietetics Spa Composizioni comprendenti amino acidi per l'uso nel trattamento di malattie associate a disfunzione mitocondriale
IT201700087359A1 (it) 2017-07-28 2019-01-28 Professional Dietetics Spa Composizioni comprendenti amino acidi per l'uso nel trattamento di malattie associate a disfunzione mitocondriale
IT202000000454A1 (it) * 2020-01-13 2021-07-13 Professional Dietetics Spa Composizioni comprendenti amino acidi per la prevenzione e il trattamento del cancro
WO2022266480A1 (en) * 2021-06-17 2022-12-22 Axcella Health Inc. Methods of predicting liver fat content and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007049818A1 (ja) * 2005-10-27 2007-05-03 Ajinomoto Co., Inc. 抗脂肪肝、抗肥満及び抗高脂血症用組成物
JP2007161642A (ja) * 2005-12-14 2007-06-28 Kyowa Hakko Kogyo Co Ltd アルコール性肝障害抑制剤
US20130084378A1 (en) * 2011-09-30 2013-04-04 Daesang Corporation Amino acid seasoning compositions comprising l-glutamic acid and l-lysine
US9597367B2 (en) * 2013-04-19 2017-03-21 Bioventures, Llc Methods for improving muscle and heart function
US10226441B2 (en) * 2014-12-09 2019-03-12 Nihon Sizen Hakkoh Co., Ltd. Aging inhibitor
KR20180029963A (ko) * 2015-05-11 2018-03-21 뉴캐슬 이노베이션 리미티드 아미노산 보충제

Also Published As

Publication number Publication date
CY1124030T1 (el) 2022-05-27
JP7347744B2 (ja) 2023-09-20
SG11202012297XA (en) 2021-01-28
CA3104839A1 (en) 2020-01-02
US20210260011A1 (en) 2021-08-26
MX2020013471A (es) 2021-02-18
LT3586837T (lt) 2021-05-10
WO2020003013A1 (en) 2020-01-02
JP2021529731A (ja) 2021-11-04
KR20210025611A (ko) 2021-03-09
ES2858355T3 (es) 2021-09-30
ZA202007834B (en) 2021-10-27
EP3586837A1 (en) 2020-01-01
EP3586837B1 (en) 2020-12-23
PH12020552254A1 (en) 2021-08-16
BR112020026431A2 (pt) 2021-03-30
DK3586837T3 (da) 2021-03-01
PL3586837T3 (pl) 2021-09-13
IT201800006725A1 (it) 2019-12-27
RS61613B1 (sr) 2021-04-29
AU2019293293A1 (en) 2021-01-14
CL2020003209A1 (es) 2021-06-04
CN112334129A (zh) 2021-02-05

Similar Documents

Publication Publication Date Title
EA202092749A1 (ru) Композиции, содержащие аминокислоты, для применения в предотвращении и лечении заболеваний печени
PH12020500190A1 (en) Compositions comprising amino acids for use in the treatment of mitochondrial dysfuntion-related diseases
MX2020008271A (es) Inhibidor de fap.
MX2018005193A (es) Proteinas de doble funcion y composicion farmaceutica que comprende las mismas.
ECSP18006465A (es) Inhibidor de la isocitrato deshidrogenasa mutada idh1 r132h
EA201890815A1 (ru) Аминокислотные композиции с модифицированным высвобождением для перорального введения
MX2019003805A (es) Activadores de flujo autofágico y fosfolipasa d y depuración de acumulaciones de proteína que incluyen tau y tratamiento de proteinopatías.
MX2019001850A (es) Formulaciones para administracion oral de principios activos.
CL2019001746A1 (es) Amidas aromáticas de ácido carboxílico
MX2020008208A (es) Agentes de unión a fibroblastos y uso de estos.
JOP20210185A1 (ar) مركبات هالو-آلِّيلامين واستخدامها
CL2020001420A1 (es) Procedimiento para la preparación de (3s)-3-(4-cloro-3-{[(2s,3r)-2-(4-clorofenil)-4,4,4-trifluor-3-metilbutanoil] amino}fenil)-3-ácido ciclopropilpropanoico y su forma cristalina para uso como principio activo farmacéutico.
MX2022013566A (es) Anticuerpo.
MY187022A (en) Compositions comprising amino acids for use in the treatment of mucositides in neoplasia patients undergoing radiation therapy and/or chemotherapy
MX2020004981A (es) Novedosos derivados de pirazolo-pirrolo-pirimidina como inhibidores de p2x3.
MX2021015652A (es) Nuevo derivado del acido aminoalcanoico que contiene un grupo bifenilo y una composicion farmaceutica antifungica que comprende el mismo.
AR109799A1 (es) Composición para el tratamiento del cabello
EA202191880A1 (ru) Композиции, содержащие аминокислоты, для применения и лечения повреждений центральной нервной системы
PH12020500189A1 (en) Compositions comprising amino acids for use in the treatment of mitochondrial dysfuntion-related diseases
CL2022001779A1 (es) Composiciones que comprenden aminoácidos para la prevención y/o el tratamiento del cáncer
NZ734845A (en) Use of short synthetic peptide for the treatment and/or prophylaxis of dry eye disease
TH2001000484A (th) องค์ประกอบซึ่งประกอบรวมด้วยกระอะมิโนสำหรับใช้ในการรักษาโรคที่เกี่ยวข้องกับการทำหน้าที่ผิดปกติของไมโครทอนเดรีย
RU2022106848A (ru) Композиции, содержащие аминокислоты, для применения в лечении заболеваний, ассоциированных с митохондриальными дисфункциями
TH2001000485A (th) องค์ประกอบซึ่งประกอบรวมด้วยกรดอะมิโนสำหรับใช้ในการรักษาโรคที่เกี่ยวข้องกับการทำหน้าที่ผิดปกติของไมโทคอนเดรีย
EA202191612A1 (ru) Введение сулькардина для лечения острой фибрилляции предсердий